In line with this, MEX3A upstream regulator E2F3 also functions as an oncogenic transcription factor in a variety of cancers 41-43, and high E2F3 levels confer poor overall survival and disease-free survival in patients with colon cancer 27. This evidence concerns the gene E2F3 and cancer.